162 related articles for article (PubMed ID: 1657575)
1. The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
Souness GW; Morris DJ
Endocrinology; 1991 Nov; 129(5):2451-6. PubMed ID: 1657575
[TBL] [Abstract][Full Text] [Related]
2. The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat.
Souness GW; Morris DJ
Endocrinology; 1989 Mar; 124(3):1588-90. PubMed ID: 2917528
[TBL] [Abstract][Full Text] [Related]
3. Mineralo- and glucocorticoid effects on renal excretion of electrolytes.
Campen TJ; Vaughn DA; Fanestil DD
Pflugers Arch; 1983 Oct; 399(2):93-101. PubMed ID: 6647008
[TBL] [Abstract][Full Text] [Related]
4. 11-Dehydrocorticosterone in the presence of carbenoxolone is a more potent sodium retainer than corticosterone.
Souness GW; Morris DJ
Steroids; 1993 Jan; 58(1):24-8. PubMed ID: 8430442
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of mineralocorticoid action of carbenoxolone.
Armanini D; Karbowiak I; Krozowski Z; Funder JW; Adam WR
Endocrinology; 1982 Nov; 111(5):1683-6. PubMed ID: 6290195
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP
Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378
[TBL] [Abstract][Full Text] [Related]
7. Other physiological considerations of protective mechanisms of mineralocorticoid action.
Souness GW; Myles K; Morris DJ
Steroids; 1994 Feb; 59(2):142-7. PubMed ID: 8191544
[TBL] [Abstract][Full Text] [Related]
8. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action.
Funder JW; Pearce PT; Myles K; Roy LP
FASEB J; 1990 Nov; 4(14):3234-8. PubMed ID: 2172062
[TBL] [Abstract][Full Text] [Related]
9. Further studies of the mineralocorticoid activity of 19-oxo-deoxycorticosterone.
Kenyon CJ; Saccoccio NA; Morris DJ
Endocrinology; 1984 Aug; 115(2):535-7. PubMed ID: 6745168
[TBL] [Abstract][Full Text] [Related]
10. Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats.
Dajani EZ; Bianchi RG; Casler JJ; Weet JF
Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):128-38. PubMed ID: 543742
[TBL] [Abstract][Full Text] [Related]
11. 5 alpha-Dihydro-11-deoxycorticosterone as a mineralocorticoid agonist and antagonist: evidence for a weak mineralocorticoid as an antagonist of potent mineralocorticoids.
Sekihara H; Yazaki Y
J Steroid Biochem Mol Biol; 1993 Apr; 45(4):235-8. PubMed ID: 8499332
[TBL] [Abstract][Full Text] [Related]
12. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.
Krozowski ZS; Funder JW
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6056-60. PubMed ID: 6310613
[TBL] [Abstract][Full Text] [Related]
13. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
Spencer RL; Kim PJ; Kalman BA; Cole MA
Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
[TBL] [Abstract][Full Text] [Related]
14. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
[TBL] [Abstract][Full Text] [Related]
16. Novel effects of deoxycorticosterone on testicular 11beta-hydroxysteroid dehydrogenase activity and plasma testosterone levels in normal and adrenalectomized rats.
Nwe KH; Morat PB; Hamid A; Fadzilah S; Khalid BA
Exp Clin Endocrinol Diabetes; 1999; 107(5):288-94. PubMed ID: 10482040
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in adrenalectomized rat.
Perrone RD; Bengele HH; Dale SL; Melby JC; Alexander EA
Am J Physiol; 1982 May; 242(5):E305-8. PubMed ID: 7081431
[TBL] [Abstract][Full Text] [Related]
18. Effect of carbenoxolone sodium on steroid-induced sodium transport in the toad bladder: further studies.
Brem AS; Matheson KL; Morris DJ
J Steroid Biochem Mol Biol; 1992 Sep; 42(8):911-4. PubMed ID: 1525050
[TBL] [Abstract][Full Text] [Related]
19. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid activity of 19-hydroxyaldosterone, 19-nor-aldosterone, and 3 beta-hydroxy-delta 5-aldosterone: relative potencies measured in two bioassay systems.
Morris DJ; Brem AS; Saccoccio NA; Pacholski M; Harnik M
Endocrinology; 1986 Jun; 118(6):2505-9. PubMed ID: 3084221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
